Beyond Air (NASDAQ:XAIR) Releases Earnings Results, Beats Expectations By $0.09 EPS

Beyond Air (NASDAQ:XAIR) announced its quarterly earnings results on Monday. The company reported ($0.15) EPS for the quarter, beating analysts’ consensus estimates of ($0.24) by $0.09, Zacks reports. Beyond Air had a negative return on equity of 227.29% and a negative net margin of 2,369.17%. During the same period in the previous year, the firm posted ($0.50) earnings per share.

Beyond Air Stock Performance

Shares of XAIR stock opened at $0.41 on Wednesday. The company has a debt-to-equity ratio of 0.37, a current ratio of 5.76 and a quick ratio of 5.38. The stock has a market cap of $31.12 million, a PE ratio of -0.29 and a beta of -0.15. The stock has a 50-day moving average of $0.42 and a 200-day moving average of $0.43. Beyond Air has a one year low of $0.30 and a one year high of $2.17.

About Beyond Air

Beyond Air, Inc operates as a commercial-stage medical device and biopharmaceutical company in the United States. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn.